Page 228 - Tata_Chemicals_yearly-reports-2019-20

The following tables provides the fair value measurement hierarchy of the Company’s financial assets and liabilities that are measured at
fair value or where fair value disclosure is required.
` in crore
As at March 31, 2020
Fair value measurement using
Quoted prices in Significant Significant
Total active markets observable unobservable
(Level 1) inputs (Level 2) inputs (Level 3)
Assets measured at fair value:
Derivative financial assets
Foreign exchange forward contracts 1.64 - 1.64 -
FVTOCI financial investments
Quoted equity instruments 1,497.23 1,497.23 - -
unquoted equity instruments 407.00 - - 407.00
FVTPL financial investments
Investment in mutual funds 1,301.33 - 1,301.33 -
There have been no transfers between levels during the period.

` in crore
As at March 31, 2019
Fair value measurement using
Quoted prices in Significant Significant
Total active markets observable unobservable
(Level 1) inputs (Level 2) inputs (Level 3)
Assets measured at fair value:
Derivative financial assets
Cross currency interest rate swaps 39.56 - 39.56 -
Options 0.20 - 0.20 -
Foreign exchange forward contracts 0.03 - 0.03 -
FVTOCI financial investments
Quoted equity instruments 1,978.84 1,978.84 - -
unquoted equity instruments 482.71 - - 482.71
FVTPL financial investments
Investment in mutual funds 2,146.26 - 2,146.26 -
Liabilities measured at fair value:
Derivative financial liabilities
Foreign exchange forward contracts 1.67 - 1.67 -
Liabilities for which fair values are disclosed
Borrowings
unsecured Non convertible debentures 250.67 250.67 - -
There have been no transfers between levels during the period.

226 I INTEGRATED ANNuAL REPORT 2019-20